Skip to main content
. 2014 May 13;5(11):3579–3589. doi: 10.18632/oncotarget.1961

Figure 3.

Figure 3

A) Inhibition of TGF-β pathway by inhibitor LY-364947 resensitized cisplatin on SKOV3 and C272 cells. B) Activation of p-Smad2 by TGF-β was inhibited by LY-364947 by western blotting.